Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea
· Delayed Price · Currency is KRW
10,440
-280 (-2.61%)
Dec 19, 2024, 3:00 PM KST
Vaxcell-Bio Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 18, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 229,932 | 516,197 | 519,865 | 660,678 | 2,517,196 | - | |
| Market Cap Growth | -36.16% | -0.71% | -21.31% | -73.75% | - | - | |
| Enterprise Value | 183,086 | 504,030 | 497,951 | 646,323 | 2,482,604 | - | |
| Last Close Price | 10000.00 | 22450.00 | 26694.20 | 33924.69 | 130774.23 | - | |
| PS Ratio | 4922.43 | 37614.61 | - | - | - | - | |
| PB Ratio | 2.93 | 6.18 | 22.29 | 21.96 | 72.61 | - | |
| P/TBV Ratio | 4.45 | 6.20 | 22.51 | 22.07 | 72.75 | - | |
| EV/Sales Ratio | 4288.08 | 36727.98 | - | - | - | - | |
| Debt / Equity Ratio | 0.04 | 0.00 | 0.00 | 0.01 | 0.01 | 0.05 | |
| Asset Turnover | 0.00 | 0.00 | - | - | - | - | |
| Quick Ratio | 22.16 | 54.78 | 67.10 | 70.51 | 31.98 | 19.19 | |
| Current Ratio | 22.43 | 55.43 | 68.06 | 71.88 | 32.29 | 19.54 | |
| Return on Equity (ROE) | -21.52% | -19.24% | -25.56% | -14.71% | -18.22% | -987.03% | |
| Return on Assets (ROA) | -16.22% | -13.18% | -18.52% | -11.05% | -11.68% | -22.49% | |
| Return on Capital (ROIC) | -16.73% | -13.41% | -19.11% | -11.30% | -11.94% | -52.09% | |
| Earnings Yield | -4.44% | -1.99% | -1.31% | -0.72% | -0.16% | - | |
| FCF Yield | -5.23% | -1.86% | -1.19% | -1.03% | -0.13% | - | |
| Buyback Yield / Dilution | -23.04% | -2.89% | -26.09% | -122.02% | -55.35% | -23.67% | |
| Total Shareholder Return | -23.04% | -2.89% | -26.09% | -122.02% | -55.35% | -23.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.